A threshold of 1.7 mg/kg of tetrahydrocannabinol (THC) in children younger than 6 years of age “may guide medical management and preventive regulations,” investigators conclude based
Clinical evidence supports effectiveness of cannabis-based medicines in people with multiple sclerosis, chronic pain, and inflammatory bowel disease, and in palliative medicine, according to a
Asking older adults about cannabis use and educating them about its effects should be a routine aspect of medical care, according to authors who studied
FDA has concluded that a new regulatory pathway for cannabidiol (CBD) products is needed that balances individuals’ desire for access to CBD products with the
FDA has issued a final guidance, “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Guidance for Industry.” This guidance provides the FDA’s current thinking on
The FDA is exploring ways it can regulate CBD in foods and supplements, the Wall Street Journal reports. “The FDA has approved a drug named
Visits to Ontario emergency departments (EDs) for cannabis hyperemesis syndrome (CHS) increased sharply in the years following the legalization of cannabis products in October 2019,
